<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" type="text/css" href="css/style-manual.css">
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
    <script src="js/script.js"></script>
</head>
<body>
<!--Glix-------------------------------------------------------->
<div class="bodyDiv" id="idGlix">
    <div class="w3-container w3-center w3-animate-left">
        <h2 class="mango">Glix</h2>
    </div>
<table class="table1">
<tr>
<th>Brand Name:
</th>
<th>
Glix
</th>
</tr>
<tr>
<td>Generic:
</td>
<td>
Gliclazide
</td>
</tr>
<tr>
<td>Strength:
</td>
<td>
80mg,30mg MR & 6Omg MR
</td>
</tr>
<tr>
<td>Dosage Form:
</td>
<td>
Tablet
</td>
</tr>
<tr>
<td>Therapeutic Class:
</td>
<td>Sulfonylurea.
</td>
</tr>
</tr>
<tr>
<td>Sub Therapeutic class: 
</td>
<td>---
</td>
</tr>
<tr>
<td>Commercial Pack & Accessories:
</td>
<td>
50’s MR: 30’s
</td>
</tr>
<tr>
<td>Price (TP):
</td>
<td>
(IP) 80mg: 7tk./Tab; <br>
30 mg: 7tk./Tab; <br>
60mg: 12 tk./tab
</td>
</tr>	
<tr>
<td>Flavour 
</td>
<td>---
</td>
</tr>
<tr>
<td>Indication: 
</td>
<td>
&#x2022; An adjunct to diet and exercise to improve glycemic control in adults with <span>type 2 diabetes mellitus</span>.

</td>
</tr>
<tr>
<td>Pregnancy: 
</td>
<td>
</td>
</tr>
<tr>
<td>Lactation: 
</td>
<td>

</td>
</tr>
<tr>
<td>Children: 
</td>
<td>

</td>
</tr>
<tr>
<td>Brand Name Justification: 
</td>
<td>
<strong>Gli</strong>clazide ensures ma<strong>x</strong>imum
Glix efficacy in T2DM=<br>Glix
</td>
</tr>
<tr>
<td>Brand Slogan: 
</td>
<td>
Glix: Rationalizes diabetic complications in non-obese type 2 diabetic patients<br>
Glix MR:Smart solution for Diabetes management
</td>
</tr>
<tr>
<td>Dosage & Administration: 
</td>
<td>
Glix 80mg:<br>
&#x2022; The usual starting dose is 40 mg to 80 mg daily with breakfast, if necessary increase up to 320 mg daily<br>
&#x2022; Dose higher than 160 mg should be divided<br>
MR Tablet:<br>
&#x2022; The initial recommended dose is 30 mg daily.<br>
&#x2022; The daily dose may vary from 30 mg to 120 mg taken
orally in <span>a single intake</span> at breakfast time.<br>
&#x2022; Presence of food has no influence the drug absorption
</td>
</tr>
<tr>
<td>Key Selling Points: 
</td>
<td>
Glix:<br>
&#x2022; Reduces platelet reactivity<br>
&#x2022; Stimulates endothelial prostacyclin synthesis<br>
&#x2022; Reduces oxidative stress<br>
&#x2022; Completely metabolized by liver and hence can be suitable for patients with severe renal insufficiency<br><br>
Glix MR:<br>
&#x2022; Effrctively controls T2DM<br>
&#x2022; Ensures intensive glucose control in patients with T2DM<br>
&#x2022; Significantly reduces relative risk of vascular complication<br>
&#x2022; Reduces the burden of renal disease in T2DM
</td>
</tr>
<tr>
<td>Target Doctor: 
</td>
<td>
&#x2022; Diabetologist<br>
&#x2022; Endocrinologist<br>
&#x2022; Medicine Specialist<br>
&#x2022; Potential GP
</td>
</tr>
<tr>
<td>Side effects: 
</td>
<td>
&#x2022; 
</td>
</tr>
<tr>
<td colspan="4">
---
</td>
</tr>
</table>

<br>


<strong>Diabetes:</strong><br>
Diabetes is a group of metabolic disorder in which persistent hyperglycaemia is caused<br>
&#8227; by <span>deficient insulin secretion</span> or<br>
&#8227; by <span>resistance to the action of insulin</span>
<br><br>

<strong>Glucose:</strong><br>
Glucose is a type of sugar that all living organism get from their foods, and body uses It for energy. It travels through bloodstream to cells for producing ENERGY.<br><br>

<strong>Insulin:</strong><br>
Insulin is a hormon produced from the beta cells of the Islets of Langerhans in pancreas. It helps to move glucose into cells to be used as energy.<br><br>

<strong>What is the role of Glucose & Insulin in body?</strong><br>
&#x2022; <span>Glucose</span> produce energy from the cells<br>
&#x2022; <span>Insulin</span> is the key to open the cells<br><br>

<strong>Diabetes is Manageable, But is not Curable
To maintain optimum blood glucose level, Diabetic patients needs:</strong><br>
&#x2022; Diet + Discipline + Drug (3D Theory)<br><br>

<strong>Glycated Haemoglobin (HbA1C):</strong><br>
It develops when Haemoglobin bind with glucose in the blood becoming ‘Glycated’. The level of Glycated hemoglobin is increased in the red blood cells of persons with poorly controlled diabetes mellitus. The
normal level for Glycated Haemoglobin is less than 7%.<br><br>

<strong>Major Drugs Used to Control Diabetes</strong><br>
Oral hypoglycemic drug<br>
&#x2022; Sulfonylurea: <br>
Glibenclamide, Glipizide, Tolbutamide, Gliclazide, Glimepiride<br>
&#x2022; Others: <br>
Metformin, Linagliptin, Sitagliptin, Vildagliptin, Empagliflozin, Dapagliflozin, Pioglitazone etc.<br><br>

<strong>Mechanism of Sulfonylureas (Glix)</strong><br>
Sulfonylureas reduce blood glucose level in two pissible ways.<br>
&#x2022; 1. They act on beta cells in the pancreas to release more insulin in to the blood stream<br>
&#x2022; 2. They also reduce Insulin resistance<br><br>
    <img src="img/Glix-1.png" alt="" class="responsive-IMG" width="375" height="300">
    <br>
    <br>

<strong>Advantages of Sulfonylureas</strong><br>
&#x2022; Major HbA1c or A1c reduction<br>
&#x2022; Well tolerated<br>
&#x2022; Suitable for renal insufficiency & DKD patients<br>
&#x2022; <span>Once-daily dosing possible</span><br>
&#x2022; Low cost<br><br>

<strong>Why Modified Release (MR) Preparations?</strong><br>
&#x2022; Modified Release (MR) formulation of Gliclazide has
been introduced for <span>ONCE DAILY</span> dosing<br>
&#x2022; 30 mg MR gives similar efficacy to 80 mg (unmodified)<br>
&#x2022; Reduces risk of severe hypoglycemia<br><br>

<table class="table6">
<tr>
<th>
<strong>Drug delivery mechanism of MR formulation:</strong><br><br>
</th>
</tr>
<tr>
<td>Gliclazide modified in a hydrophilic matrix base
</td>
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>It swell in contact with gastrointestinal fluid
</td>
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>Tablet from gel layer
</td>
</tr>
<tr>
<td>&#8681;
</td>
</tr>
<tr>
<td>Gradually release Gliclazide over 24 hours
</td>
</tr>
</table>
<br>
    <img src="img/Glix-2.jpg" alt="" class="responsive-IMG" width="375" height="300">
    <br>
    <br>
    <img src="img/Glix-3.jpg" alt="" class="responsive-IMG" width="375" height="300">
    <br>
    <br>
    <img src="img/Glix-4.jpg" alt="" class="responsive-IMG" width="375" height="300">
    <br>
    <br>
    <img src="img/Glix-5.jpg" alt="" class="responsive-IMG" width="375" height="300">
    <br>
    <br>
    <img src="img/Glix-6.png" alt="" class="responsive-IMG" width="375" height="300">
    <br>
    <br>
    <img src="img/Glix-7.png" alt="" class="responsive-IMG" width="375" height="300">
    <br>
    <br>

<strong>Q. Why is Glix formulated as Modified Release (MR) Preparations?</strong><br>
Ans:<br>
A Modified Release (MR) formulation of Gliclazide has been introduced for ONCE DAILY dosing. Interestingly, the 30 mg preparation of Gliclazide MR gives similar efficacy to 80 mg of unmodified Gliclazide and reduces risk of severe hypoglycemia.<br><br>

<strong>Q. Write down the advantages of Gliclazide (Glix) over other oral hypoglycemic drugs.</strong><br>
Ans:<br>
&#8227; Major A1c reduction<br>
&#8227; Well tolerated<br>
&#8227; Suitable for renal insufficiency & Progression of DKD patients except Glyburide<br>
&#8227; Once-daily dosing (MR)<br>
&#8227; low cost generics<br><br>

<strong>Q. Write down the mechanism of action of Glix Tablet.</strong><br>
Ans:<br>
&#8227; Gliclazide binds to the β cell sulfonyl urea receptor (SUR1).<br>
&#8227; This binding subsequently blocks the ATP sensitive potassium channels.<br>
&#8227; As a results decrease in potassium efflux leads to depolarization of the β cells.<br>
&#8227; This opens calcium channels in the β cell resulting in calmodulin activation, which in turn leads to insulin secretion.<br><br>
    <img src="img/Glix-8.jpg" alt="" class="responsive-IMG" width="375" height="300">
    <br>
</div>   
<footer>
    <p>© 2024 Md. Nurullah. All rights reserved.</p>
</footer>
<center><div class="ovalEnd">The End-Glix</div></center><!--End Line---->
</body>
</html>